⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24210681 | 0.75 | — | — | |
| SCHEMBL26304336 | 0.73 | — | — | |
| SCHEMBL25497315 | 0.70 | — | — | |
| SCHEMBL21649850 | 0.69 | SMN1; SMN2 (0.45) | — | |
| SCHEMBL18583338 | 0.68 | — | — | |
| SCHEMBL26701187 | 0.68 | — | — | |
| SCHEMBL26298525 | 0.68 | — | — | |
| SCHEMBL23436009 | 0.68 | — | — | |
| SCHEMBL25502825 | 0.67 | — | — | |
| SCHEMBL19251524 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230203060-A1 | FUSED TRICYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF | GENFLEET THERAPEUTICS (SHANGHAI) INC. (CN) | 2023-06-29 | — | — | US | disclosed |